Maxim Group

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) recent results from a prospective cystic fibrosis treatment suggests the product has a high risk of failure, an analyst said Tuesday. Maxim Group's Jason Kolbert maintained a Hold rating on Vertex with a $121 target. Vertex is off 5 percent since...

In a report published Friday, Maxim Group analyst Jason Kolbert said that his thesis on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) remains unchanged for the following reasons: Kalydeco (ivafcaftor) has been approved for children with one of ten gating/conductance mutations, adding an...

In a report published Monday, Maxim Group analyst Rick Snyder maintained a Hold rating on six of the seven companies being discussed in the retail sector. The only company with a Buy rating was Kohl's Corp (NYSE: KSS), with a price target of $77. In the report Maxim Group noted, "Again this week,...

Analysts at Maxim Group downgraded Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Thursday from Buy to Hold and lowered their price target from $148.00 to $121.00. The company released its Q4 earnings report on Wednesday. Vertex reported an earnings loss of $0.55 per share on revenue of $...

Analysts at Maxim Group initiated coverage on Rocket Fuel (NASDAQ: FUEL) with a Sell rating. The target price for Rocket Fuel is set to $10. Rocket Fuel shares have dropped 67.33% over the past 52 weeks, while the S&P 500 index has gained 14.78% in the same period. Rocket Fuel's shares rose 0....

Analysts at Maxim Group initiated coverage on VMware (NYSE: VMW) with a Buy rating. The target price for VMware is set to $100. VMware shares have gained 11.99% over the past 52 weeks, while the S&P 500 index has surged 13.83% in the same period. VMware's shares surged 2.57% to close at $86.50...

Analysts at Maxim Group downgraded J.C. Penney Company (NYSE: JCP) from Hold to Sell. J.C. Penney shares have dropped 4.50% over the past 52 weeks, while the S&P 500 index has gained 13.21% in the same period. J.C. Penney's shares slipped 2.62% to $7.44 in pre-market trading.

Analysts at Maxim Group downgraded Cypress Sharpridge Investments (NYSE: CYS) from Buy to Hold and removed the price target of $10. CYS Investments shares have jumped 21.79% over the past 52 weeks, while the S&P 500 index has gained 22.11% in the same period. CYS Investments' shares declined 0...

Analysts at Maxim Group upgraded Kohl's (NYSE: KSS) from Hold to Buy. The target price for Kohl's has been raised from $48 to $68. Kohl's shares have jumped 15.00% over the past 52 weeks, while the S&P 500 index has gained 22.11% in the same period. Kohl's shares rose 0.54% to close at $59.11...

Analysts at Maxim Group initiated coverage on iGATE (NASDAQ: IGTE) with a Buy rating. The target price for iGATE is set to $52. iGATE shares have surged 55.43% over the past 52 weeks, while the S&P 500 index has gained 18.08% in the same period. iGATE's shares gained 0.26% to close at $34.63...

Analysts at Maxim Group initiated coverage on shares of IAC/InterActiveCorp (NASDAQ: IACI) with a Buy rating. The target price for IAC/InterActiveCorp is set to $85. IAC/InterActiveCorp shares have surged 28.90% over the past 52 weeks, while the S&P 500 index has gained 17.18% in the same...

Analysts at Maxim Group initiated coverage on shares of The KEYW Holding (NASDAQ: KEYW) with a Buy rating. The target price for KEYW Holding is set to $19. KEYW Holding shares have declined 3.41% over the past 52 weeks, while the S&P 500 index has gained 14.74% in the same period. KEYW Holding'...

Maxim Group analyst Jason Kolbert raised the price target on Buy rated Achillion Pharmaceuticals (NASDAQ: ACHN) from $6.00 to $22.00. Kolbert wrote that Achillion is set for "fundamental progress" with multiple catalysts. The analyst highlighted the experimental hepatitis C drugs and the potential...

In a report published Thursday, Maxim Group analyst Echo He initiated coverage on YY (NASDAQ: YY) with a Buy rating and $90.00 price target. In the report, Maxim Group noted, “We are initiating coverage of YY Inc. (YY) with a Buy rating and a 12-month price target of $90. YY is a leading internet...